Today: 3 April 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Elevance Health stock rebounds nearly 6% after earnings — here’s what matters before Thursday’s trade

Elevance Health stock rebounds nearly 6% after earnings — here’s what matters before Thursday’s trade

Elevance Health shares rose 5.9% to $341.85 Wednesday after plunging 14% the previous session. The insurer projected 2026 adjusted earnings of at least $25.50 per share, below analyst forecasts, and expects a small revenue decline. Fourth-quarter operating revenue rose 10% to $49.3 billion. Medicare Advantage payment changes and rising medical costs continue to drive volatility in managed-care stocks.
29 January 2026
··
Uber stock drops 1.8% — Waabi robotaxi deal and Dutch driver ruling set up earnings test

Uber stock drops 1.8% — Waabi robotaxi deal and Dutch driver ruling set up earnings test

Uber shares fell 1.8% to $79.78 Wednesday, underperforming a flat S&P 500. A Dutch court ruled Uber drivers can be classified as self-employed, reversing a 2021 decision. Uber pledged up to $250 million to Waabi, aiming to deploy at least 25,000 robotaxis on its platform. Investors weighed regulatory and automation developments ahead of Uber’s Feb. 4 earnings report.
29 January 2026
·····
Abbott stock slides after CEO’s $2 million buy hits SEC filing — what investors watch next

Abbott stock slides after CEO’s $2 million buy hits SEC filing — what investors watch next

Abbott shares fell 2.1% to $106.05 Wednesday after CEO Robert Ford bought about $2 million in stock through a family trust, according to an SEC filing. The stock has dropped 12% in five sessions following a disappointing earnings report and a price target cut by Argus. Investors are watching for updates at major medical conferences starting Jan. 29 in New Orleans.
29 January 2026
·
Chevron stock rises as Reuters reports March surge in Venezuelan crude exports to U.S.

Chevron stock rises as Reuters reports March surge in Venezuelan crude exports to U.S.

Chevron shares rose 0.5% to $169.91 Wednesday after Reuters reported the company plans to boost Venezuelan crude exports to about 300,000 barrels per day in March. Oil prices climbed over 1%, lifting energy stocks and sending the S&P 500 energy sector up 0.7%. Chevron traded between $168.20 and $170.42 on 6.8 million shares. Investors await Chevron’s earnings and outlook Friday.
29 January 2026
·
IBM stock price whipsaws after earnings beat, leaving traders with one big question for Thursday

IBM stock price whipsaws after earnings beat, leaving traders with one big question for Thursday

IBM shares closed nearly flat after volatile after-hours trading Wednesday, despite beating fourth-quarter revenue and profit estimates. Red Hat growth slowed to 10% following a U.S. government shutdown. IBM reported $19.69 billion in revenue and $4.52 adjusted EPS, and forecast over 5% revenue growth for 2026. The stock last traded at $294.16, down from a $324.20 after-hours high.
29 January 2026
··
Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Danaher shares fell 4.8% to $224.54 after its 2026 profit outlook matched analyst expectations. The company beat fourth-quarter profit and revenue estimates, posting $6.8 billion in revenue and $2.23 per share in adjusted earnings. Trading volume more than doubled its 50-day average. Investors focused on the pace of recovery and upcoming results from rival Thermo Fisher.
29 January 2026
··
Caterpillar stock edges up ahead of earnings as AI data-center power deal puts CAT in focus

Caterpillar stock edges up ahead of earnings as AI data-center power deal puts CAT in focus

Caterpillar shares closed Wednesday up 0.7% at $643.28 after landing a 2-gigawatt data-center power contract and an analyst price target hike. The company will report fourth-quarter and full-year results before the U.S. market opens Thursday. Investors await earnings guidance as analysts expect a 9% year-over-year profit drop.
29 January 2026
····
KLA (KLAC) stock edges up ahead of earnings as chip-tool signals roll in

KLA (KLAC) stock edges up ahead of earnings as chip-tool signals roll in

KLA shares rose 0.7% to $1,627.20 Wednesday and gained another 1.4% after hours ahead of its quarterly earnings report due Thursday. Analysts expect revenue near $3.26 billion and adjusted earnings around $8.80 per share. Evercore ISI raised its price target to $1,700. KLA’s results follow upbeat forecasts from ASML and Lam Research amid strong AI-driven chip demand.
29 January 2026
··
Bank of America stock slips: Fed pause, “Trump Accounts” and the next catalysts for BAC

Bank of America stock slips: Fed pause, “Trump Accounts” and the next catalysts for BAC

Bank of America shares fell 0.7% to $51.81 Wednesday as major U.S. banks closed mixed. The Fed held rates at 3.50%-3.75%, with two officials voting for a cut. Reuters reported BofA will match the government’s $1,000 seed for proposed “Trump Accounts” for employees’ children. Vito Lo Piccolo was named BofA’s new country executive for Italy.
29 January 2026
··
GE Aerospace stock price slips after hours as Boeing flags GE9X issue; traders eye next catalyst

GE Aerospace stock price slips after hours as Boeing flags GE9X issue; traders eye next catalyst

GE Aerospace shares fell 1.7% to $292.48 in after-hours trading Wednesday after Boeing flagged a potential durability issue with GE9X engines for the 777-9. GE is conducting on-wing inspections and working on a fix. The company also completed ground testing of a hybrid-electric turbofan system in Ohio. GE’s trading volume topped its 50-day average as the stock remains 12% below its Jan. 6 high.
29 January 2026
··
Johnson & Johnson stock price rises as Morgan Stanley upgrades JNJ and FDA clears new Darzalex regimen

Johnson & Johnson stock price rises as Morgan Stanley upgrades JNJ and FDA clears new Darzalex regimen

Johnson & Johnson shares rose 1.5% to $227.72 Wednesday after Morgan Stanley upgraded the stock and raised its price target to $262. The FDA approved expanded use of J&J’s Darzalex Faspro for newly diagnosed multiple myeloma patients ineligible for stem cell transplants. A regulatory filing showed CEO Joaquin Duato’s spouse sold about $22 million in shares.
29 January 2026
··
1 … 208 209 210 211 212 … 732

Stock Market Today

  • Cotton Futures Show Mixed Trading as Export Sales Hit Six-Week High
    April 3, 2026, 1:04 AM EDT. Cotton futures displayed mixed movement Thursday, ranging from a 14-point drop to a 4-point gain by midday. The U.S. dollar index rose by 0.347 to 99.805. Crude oil prices jumped $10.54 following President Trump's comments on prolonged Middle East tensions. Export sales of 25/26 cotton hit a six-week high at 371,475 running bales (RB) in the week ending March 26, surpassing last year's levels. New crop sales reached 117,271 RB, the second highest this marketing year. February cotton exports hit a 10-year low for the month at 1.072 million bales but were up 15.51% from January. ICE certified stocks held steady at 114,665 bales. Cotton prices varied with May contract down 8 points at 70.68 cents and July up 4 points at 72.98 cents per pound.
Go toTop